Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesEndocrinologyNeighborhood Health Plan RI Continuous Glucose Mon…
    Ask Trek AI about this page
    CurrentNeighborhood Health Plan of Rhode IslandPolicy N/A

    Continuous Glucose Monitoring (CGM)

    Customize your policy alerts

    Sign up for all Neighborhood Health Plan of Rhode Island policy alerts

    Know when Neighborhood Health Plan of Rhode Island releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs prior authorization, coverage criteria, and quantity limits for continuous glucose monitoring systems for Neighborhood Health Plan of Rhode Island members across specified product lines.

    Policy Summary
    PayerNeighborhood Health Plan of Rhode Island
    PolicyContinuous Glucose Monitoring (CGM)
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateFeb 11, 2026
    Last ReviewFeb 11, 2026
    Next Review DateFeb 11, 2026
    Key ActionObtain prior authorization—authorizations of up to 12 months may be granted when criteria are met.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    12 monthsauthorization/coverage duration
    Prior authauthorization requirement

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Device limits listed
    device/sensor limits
    RI productsapplicability

    Coverage criteria and limits for Continuous Glucose Monitoring

    Initial/Authorization Criteria

    Covered when ANY of the following are met and prior authorization is obtained:

    Initial coverage criteria

    • Member is currently utilizing non-basal insulin for the treatment of diabetes.

      Authorization may be granted for 12 months.

    • Member has Type 1 or Type 2 Diabetes Mellitus AND is at high risk of hypoglycemia, recurring episodes of hypoglycemia, or hypoglycemia unawareness.

      Authorization may be granted for 12 months.

    Quantity Limits / Coverage Duration

    Quantity limits and duration:

    Device-specific supply limits: Medtronic Guardian sensor: 4 sensors per 28 days; Medtronic Enlite sensor: 5 sensors per 30 days; Medtronic Guardian transmitter: rechargeable, lasts 365 days; Senseonics Eversense E3 sensor: 1 sensor per 180 days; Senseonics Eversense E3 transmitter: rechargeable, lasts 365 days; Senseonics Eversense sensor: 1 sensor per 90 days; Senseonics Eversense transmitter: rechargeable, lasts 365 days.see device-specific intervals

    Coverage duration: 12 months.

    This policy does not apply to the Extended Family Planning (EFP) product. Services and devices addressed in this document are excluded from coverage for members whose benefits are provided under EFP.

    For members enrolled in Medicare dual-eligible products (INTEGRITY for Duals/FIDE and Duals CONNECT/CO-DSNP), CMS National Coverage Determinations (NCDs), Local Coverage Determinations (LCDs), Local Coverage Articles (LCAs), and other Medicare guidelines take precedence for coverage and medical necessity determinations. If an applicable Medicare NCD/LCD/LCA exists, Neighborhood follows that guidance. If Medicare guidance is absent or incomplete, Neighborhood will: for FIDE members, defer to the Rhode Island EOHHS guidance or widely used peer-reviewed guidelines (for example, InterQual® or internal Clinical Medical Policies) as secondary coverage through the member's Medicaid benefit; and for CO-DSNP members, defer to widely used peer-reviewed guidelines (for example, InterQual® or internal Clinical Medical Policies).

    Coding, duration, and code groups

    Covered Codesmixed
    No codes listed
    Coverage duration
    Coverage duration12 months
    Device-specific noteAuthorizations may be granted for 12 months in accordance with device supply intervals
    Renewal expectationPrior authorization must be obtained for each 12-month authorization period

    Prior authorization, submission, and provider requirements

    Prior Authorization

    Prior Authorization Required

    Prior authorization required. An authorization of up to 12 months may be granted when either: the member is currently utilizing non‑basal insulin for the treatment of diabetes, OR the member has Type 1 or Type 2 diabetes mellitus and is at high risk of hypoglycemia, has recurring episodes of hypoglycemia, or has hypoglycemia unawareness.

    • Authorization duration: up to 12 months when criteria are met
    • Clinical criteria: current use of non‑basal insulin OR (Type 1 or Type 2 diabetes AND high risk of hypoglycemia / recurrent hypoglycemia / hypoglycemia unawareness)
    Denial Risk

    Denial Risk if Not Authorized

    Action required. Lack of prior authorization will result in denial of payment for the service or product.

    Background and rationale

    A continuous glucose monitoring system (CGMS) is an FDA-approved device that records glucose levels continuously throughout the day and night and automatically records average glucose while the person continues daily activities. CGMS devices are intended to assist in outpatient glycemic management by providing trend information to inform treatment adjustments.

    Key definitions

    CGMS (Continuous Glucose Monitoring System) definition
    DefinitionA continuous glucose monitoring system (CGMS) is an FDA-approved device that records glucose levels throughout the day and night and automatically records an average glucose level while the person continues daily activities.
    Primary purposeFacilitates adjustments in therapy to improve glycemic control in the outpatient setting.
    Operational contextRecords glucose continuously to assist with real-time and retrospective glycemic management.
    Policy Summary
    PayerNeighborhood Health Plan of Rhode Island
    PolicyContinuous Glucose Monitoring (CGM)
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateFeb 11, 2026
    Last ReviewFeb 11, 2026
    Next Review DateFeb 11, 2026
    Key ActionObtain prior authorization—authorizations of up to 12 months may be granted when criteria are met.
    SourceLink
    On This Page
    Coverage criteria and limits for Continuous Glucose MonitoringCoding, duration, and code groupsPrior authorization, submission, and provider requirementsBackground and rationaleKey definitions
    Note

    How to Request Authorization

    How to request authorization: Access prior authorization request forms and submission instructions on Neighborhood Health Plan of Rhode Island's website. Providers should: 1) Go to www.nhpri.org; 2) Click 'Providers'; 3) Click 'Provider Resources'; 4) Click 'Forms'; 5) Select 'Click here for a list of prior authorization request forms' and choose the appropriate form (forms are listed alphabetically).

    • Website: www.nhpri.org → Providers → Provider Resources → Forms → 'Click here for a list of prior authorization request forms'
    • A phone messaging system is available for requests/inquiries during and outside business hours: 1-800-963-1001
    • For coding guidance, reference the Authorization Quick Reference on the website
    Documentation Required

    Provider Submission Guidance

    Provider reminder: Use the official prior authorization request form and follow the submission channels specified by Neighborhood. Incomplete requests or use of incorrect forms may delay processing.